Terms: = Head and neck cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Prognosis
24 results:
1. Treatment for smarcb1 (INI-1) deficient sinonasal tumor: a single-institution study.
Wang T; Wang J; Tang T; Wang L; Li Y; Song X
Neoplasma; 2023 Dec; 70(6):804-810. PubMed ID: 38247337
[TBL] [Abstract] [Full Text] [Related]
2. smarcb1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological study of pseudomyogenic hemangioendothelioma.
Yang N; Huang Y; Yang P; Yan W; Zhang S; Li N; Feng Z
Diagn Pathol; 2023 Feb; 18(1):25. PubMed ID: 36803395
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic smarcb1 Deficient Skin Carcinoma With Neuroendocrine Differentiation in the Parotid Glands Clinically Mimicking Primary Salivary Gland Malignancy: Unusual Case With Diagnostic Pitfalls.
Fang F; Zhang QI; Pinto-Cuberos JM; Lai J
Anticancer Res; 2022 Aug; 42(8):3971-3974. PubMed ID: 35896245
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of the diagnosis and treatment of patients with smarcb1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
6. Diffuse spinal cord metastasis after resection of smarcb1 sinonasal carcinoma manifesting with a right foot drop-a case report.
da Silva MA; Bentes RGL; Teixeira HS; Carvalho BM; Queiroz ALG; Schmid MF; Lima KDF; Ferreira WSM; Campos CMS; Neto MR; Baeta AM
Spinal Cord Ser Cases; 2022 Jul; 8(1):64. PubMed ID: 35778377
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Diagnosis and Treatment Analyses on smarcb1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature.
Wang R; Wang L; Fang J; Zhong Q; Hou L; Ma H; Feng L; He S; Wang C; Zhang L
World Neurosurg; 2022 May; 161():e229-e243. PubMed ID: 35123020
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a glioma functional network from gene fitness data using machine learning.
Xiang CX; Liu XG; Zhou DQ; Zhou Y; Wang X; Chen F
J Cell Mol Med; 2022 Feb; 26(4):1253-1263. PubMed ID: 35044082
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological characteristics of smarcb1(ini1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
10. Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
Taghizadeh H; Müllauer L; Mader RM; Füreder T; Prager GW
Wien Klin Wochenschr; 2021 Jan; 133(1-2):32-40. PubMed ID: 33296026
[TBL] [Abstract] [Full Text] [Related]
11. Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2.
Douglas JE; Kaufman AC; Rajasekaran K
ORL J Otorhinolaryngol Relat Spec; 2021; 83(1):47-51. PubMed ID: 33017834
[TBL] [Abstract] [Full Text] [Related]
12. Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review.
Akaki M; Ishihara A; Nagai K; Naono H; Taguchi K; Yamamoto H; Tanaka H; Kataoka H
Head Neck Pathol; 2021 Mar; 15(1):341-351. PubMed ID: 32488734
[TBL] [Abstract] [Full Text] [Related]
13. Epithelioid rhabdomyosarcoma: Report of the first case in the jaw.
de Aguiar MCF; de Noronha MS; Silveira RL; Araújo JAD; Werkema FS; Bell D; Caldeira PC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):e308-e315. PubMed ID: 32173396
[TBL] [Abstract] [Full Text] [Related]
14. smarcb1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract] [Full Text] [Related]
15. [smarcb1 (ini1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
[No Abstract] [Full Text] [Related]
16. smarcb1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
[TBL] [Abstract] [Full Text] [Related]
17. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
Gomez-Acevedo H; Patterson JD; Sardar S; Gokden M; Das BC; Ussery DW; Rodriguez A
BMC Cancer; 2019 Aug; 19(1):827. PubMed ID: 31438887
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
[TBL] [Abstract] [Full Text] [Related]
19. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathologic features of atypical spindle cell lipomatous tumor].
Zhao M; Wang YB; Yan YJ; Wang W; Ru GQ; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):99-104. PubMed ID: 29429160
[No Abstract] [Full Text] [Related]
[Next]
